4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-25-014160
Options or other derivatives
- General Counsel acquired 102,000 shares (grant or award)
From the SEC's structured data for this filing
ArriVent BioPharma, Inc. Filed Acc 0001104659-25-014160
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…